TELO: Telomir Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 81.85
Enterprise Value ($M) 80.67
Book Value ($M) 0.64
Book Value / Share 0.02
Price / Book 127.28
NCAV ($M) 0.64
NCAV / Share 0.02
Price / NCAV 127.28

Profitability (mra)
Return on Invested Capital (ROIC) -22.45
Return on Assets (ROA) -4.72
Return on Equity (ROE) -5.48

Liquidity (mrq)
Quick Ratio 1.94
Current Ratio 1.94

Balance Sheet (mrq) ($M)
Current Assets 1.32
Assets 1.32
Liabilities 0.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.24
Net Income -16.53

Cash Flow Statement (mra) ($M)
Cash From Operations -5.07
Cash from Investing 0.00
Cash from Financing 6.34

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 17,181 86,466 19.87
2025-05-12 25,818 142,318 18.14
2025-05-09 43,318 92,296 46.93
2025-05-08 43,104 219,465 19.64

(click for more detail)

Similar Companies
SXTP – 60 Degrees Pharmaceuticals, Inc. SYBX – Synlogic, Inc.
TCRT – Alaunos Therapeutics, Inc. TENX – Tenax Therapeutics, Inc.
TGTX – TG Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io